Skip to content

Clinical Observation on the Efficacy of Auricular Acupuncture in the Treatment of Chronic Insomnia

Clinical Observation on the Efficacy of Auricular Acupuncture in the Treatment of Chronic Insomnia

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092375
Enrollment
Unknown
Registered
2024-11-14
Start date
2024-04-30
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Experimental group:Auricular acupuncture therapy, alternating between left and right ears, 3 times per week for 4 consecutive weeks.
Control group:Transcutaneous auricular vagus nerve stimulation (taVNS) treatment, twice daily in the morning and evening, for 4 consecutive weeks.

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)Meet the diagnostic criteria for chronic insomnia disorder according to DSM-5; (2)Insomnia Severity Index (ISI) score >= 8; (3)Both males and females, aged between 18 and 65 years (inclusive); (4)Have not received acupuncture treatment within the past month; (5)Willing to receive auricular acupoint electrical stimulation treatment; (6)Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the above inclusion criteria; (2) Exclude insomnia caused by organic mental disorders or psychoactive substances and non-addictive substances; (3) Those allergic to the experimental auricular acupoint patches or taVNS devices used in this protocol; (4) Those with skin damage at the auricular acupoints or unable to receive treatment due to other reasons; (5) Pregnant, preparing for pregnancy, lactating women, or women who cannot take effective contraceptive measures; (6) Those with severe primary diseases such as cardiovascular, renal, hematopoietic system, liver disease, or mental illness; (7) Those with a history of suicidal tendencies or behaviors, moderate to severe depression (Hamilton Depression Rating Scale HAMD >=18), moderate to severe anxiety (Hamilton Anxiety Rating Scale HAMA >=14), schizophrenia, or other mental disorders; (8) Subjects with alcohol and drug abuse; (9) Those who have participated in other clinical drug or non-drug trials within the past 6 months; (10) Those unable to complete the experiment or deemed ineligible by the researchers for other reasons.

Design outcomes

Primary

MeasureTime frame
Insomnia Severity Index scale;Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
sleep diary;actigraphy;Heart Rate Variability (HRV);Traditional Chinese Medicine Symptom Checklist;Electroencephalogram;Functional Magnetic Resonance Imaging (fMRI) ;

Countries

China

Contacts

Public ContactWenjing Zhang

Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine

zhangwenjing@shutcm.edu.cn+86 186 1636 0246

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026